These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29372915)

  • 1. Removal of the Fe(iii) site promotes activation of the human cystic fibrosis transmembrane conductance regulator by high-affinity Zn(ii) binding.
    Wang G
    Metallomics; 2018 Feb; 10(2):240-247. PubMed ID: 29372915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis for Fe(III)-Independent Curcumin Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Activity.
    Wang G
    Biochemistry; 2015 May; 54(18):2828-40. PubMed ID: 25867080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.
    Wang W; Roessler BC; Kirk KL
    J Biol Chem; 2014 Oct; 289(44):30364-30378. PubMed ID: 25190805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.
    Wang W; Bernard K; Li G; Kirk KL
    J Biol Chem; 2007 Feb; 282(7):4533-4544. PubMed ID: 17178710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains.
    Csanády L; Chan KW; Seto-Young D; Kopsco DC; Nairn AC; Gadsby DC
    J Gen Physiol; 2000 Sep; 116(3):477-500. PubMed ID: 10962022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Zn(2+) binding to cysteine-substituted cystic fibrosis transmembrane conductance regulator constructs regulates channel gating and curcumin potentiation.
    Wang G; Linsley R; Norimatsu Y
    FEBS J; 2016 Jul; 283(13):2458-75. PubMed ID: 27175795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gating by a high affinity Fe3+ bridge between the regulatory domain and cytoplasmic loop 3.
    Wang G
    J Biol Chem; 2010 Dec; 285(52):40438-47. PubMed ID: 20952391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between inhibitory ferric and stimulatory curcumin regulates phosphorylation-dependent human cystic fibrosis transmembrane conductance regulator and ΔF508 activity.
    Wang G
    Biochemistry; 2015 Feb; 54(7):1558-66. PubMed ID: 25635662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations.
    Wang W; Fu L; Liu Z; Wen H; Rab A; Hong JS; Kirk KL; Rowe SM
    Am J Physiol Lung Cell Mol Physiol; 2020 Nov; 319(5):L770-L785. PubMed ID: 32877225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.
    Chen JH
    J Biol Chem; 2020 Apr; 295(14):4577-4590. PubMed ID: 32102849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
    Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
    Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating.
    Fu J; Ji HL; Naren AP; Kirk KL
    J Physiol; 2001 Oct; 536(Pt 2):459-70. PubMed ID: 11600681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator.
    Wang G
    J Biol Chem; 2011 Jan; 286(3):2171-82. PubMed ID: 21059651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
    Basso C; Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
    Carson MR; Travis SM; Welsh MJ
    J Biol Chem; 1995 Jan; 270(4):1711-7. PubMed ID: 7530246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface.
    Chin S; Yang D; Miles AJ; Eckford PDW; Molinski S; Wallace BA; Bear CE
    J Biol Chem; 2017 Feb; 292(5):1988-1999. PubMed ID: 28003367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.
    Wei S; Roessler BC; Icyuz M; Chauvet S; Tao B; Hartman JL; Kirk KL
    FASEB J; 2016 Mar; 30(3):1247-62. PubMed ID: 26606940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.
    Okeyo G; Wang W; Wei S; Kirk KL
    J Biol Chem; 2013 Jun; 288(24):17122-33. PubMed ID: 23620589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.